MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
24h
Current
Min
5.8
Max
6.1
Recommendations | Buy |
---|---|
12 Months Forecast | +46.82% upside |
Next Earnings | 7 May 2025 |
---|
By Acuity
50%
50%
180 / 386 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
5.7 / 6.54 Support & Resistance
Past performance is not a reliable indicator of future results.
7 Mar 2025, 21:54 UTC
Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring
DJ
Read
16 Jan 2025, 16:17 UTC
Atara Shares Sink After FDA Stalls Cancer Treatment
DJ
Read
16 Jan 2025, 14:31 UTC
FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 9 USD 46.82%
High 17 USD
Low 3 USD
Based on 5 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
5 ratings
2
Buy
3
Hold
0
Sell
Based on 5 analysts giving stock ratings to Atara Biotherapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Very Strong Bearish Evidence
All events are bearish.
Intermediate Term
Strong Bearish Evidence
All events are bearish.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
$